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Abstract
Background: Insulin-like growth factor binding protein-2 (IGFBP-2) is a secreted protein that binds and regulates IGF actions
in controlling growth, development, reproduction, and aging. Elevated expression of IGFBP-2 is often associated with
progression of many types of cancers.
Methodology/Principal Findings: We report the identification and characterization of two IGFBP-2 genes in zebrafish and
four other teleost fish. Comparative genomics and structural analyses suggest that they are co-orthologs of the human
IGFBP-2 gene. Biochemical assays show that both zebrafish igfbp-2a and -2b encode secreted proteins that bind IGFs. These
two genes exhibit distinct spatiotemporal expression patterns. During embryogenesis, IGFBP-2a mRNA is initially detected
in the lens, then in the brain boundary vasculature, and subsequently becomes highly expressed in the liver. In the adult
stage, liver has the highest levels of IGFBP-2a mRNA, followed by the brain. Low levels of IGFBP-2a mRNA were detected in
muscle and in the gonad in male adults only. IGFBP-2b mRNA is detected initially in all tissues at low levels, but later
becomes abundant in the liver. In adult males, IGFBP-2b mRNA is only detected in the liver. In adult females, it is also found
in the gut, kidney, ovary, and muscle. To gain insights into how the IGFBP-2 genes may have evolved through partitioning
of ancestral functions, functional and mechanistic studies were carried out. Expression of zebrafish IGFBP-2a and -2b caused
significant decreases in the growth and developmental rates and their effects are comparable to that of human IGFBP-2.
IGFBP-2 mutants with altered IGF binding-, RGD-, and heparin-binding sites were generated and their actions examined.
While mutating the RGD and heparin binding sites had little effect, altering the IGF binding site abolished its biological
activity.
Conclusions/Significance: These results suggest that IGFBP-2 is a conserved regulatory protein and it inhibits growth and
development primarily by binding to and inhibiting IGF actions in vivo. The duplicated IGFBP-2 genes may provide
additional flexibility in the regulation of IGF activities.
Citation: Zhou J, Li W, Kamei H, Duan C (2008) Duplication of the IGFBP-2 Gene in Teleost Fish: Protein Structure and Functionality Conservation and Gene
Expression Divergence. PLoS ONE 3(12): e3926. doi:10.1371/journal.pone.0003926
Editor: Patrick Callaerts, Katholieke Universiteit Leuven, Belgium
Received September 8, 2008; Accepted November 17, 2008; Published December 12, 2008
Copyright:  2008 Zhou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by NSF Research Grant IOB 0110864 and by a fellowship from the Changjiang Scholars Program to CD. JZ was supported in
part by a scholarship from the Chinese Academy of Sciences and WL was supported in part by a fellowship from the Guangxi Government during this study. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: cduan@umich.edu
Introduction
Peptides of the insulin-like growth factor (IGF) and insulin
family control growth, metabolism, reproduction, and longevity in
a wide variety of animals ranging from invertebrates to humans. In
extracellular fluids, these peptides are bound to and regulated by a
family of IGF binding proteins (IGFBPs) and IGFBP related
proteins [1,2,3]. Most IGFBPs are present in circulation, where
they act to prolong the half-life of circulating IGFs. IGFBPs are
also expressed in many peripheral tissues and are present in
various biological fluids. In these local environments, IGFBPs
regulate the availability of IGFs to the cell surface IGF receptors,
thereby regulating the net biological activity of the IGF signaling
pathway. Indeed, studies using a wide variety of mammalian cell
culture systems have shown that IGFBPs have the ability to inhibit
and/or potentiate the biological actions of IGFs, and some
IGFBPs even exhibit ligand-independent biological activities in
vitro [2,4,5].
There are six distinct IGFBPs, designated as IGFBP-1 to -6, and
each is coded by a single copy gene in humans and other
mammals [2,4]. These IGFBPs all contain a highly conserved N-
terminal domain, a conserved C-terminal domain, and a variable
central linker (L) domain. The N-domain contains 12 conserved
cysteine residues. C-domains have six conserved cysteine residues.
These cysteine residues form intra-domain disulfide bonds [6,7]
and help to shape the globular structure of the N- and C-domains.
The divergent L-domain often contains sites for post-translational
regulation, including glycosylation, phosphorylation, and proteol-
ysis. Despite similar domain arrangements, each IGFBP has
distinct structural features. For example, IGFBP-2 has an arginine-
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binding domain/motif (HBD) in its L domain. Comparative
studies have shown that the gene, protein primary structure, and
biological actions of IGFBPs are conserved in non-mammalian
vertebrates [8]. In agreement with these structural features, both
IGF- dependent and independent actions of IGFBP-2 has been
reported in various mammalian culture systems, and RGD and/
or heparin binding motifs have been implicated in the IGF-
independent actions on cell growth and migration [9].
Ubiquitous expression of IGFBP-2 transgenes results in growth
inhibition in mice [10,11]. Although IGFBP-2 is the most
abundantly expressed IGFBP in fetal tissues, the IGFBP-2
knockout mice were viable and fertile, and their prenatal and
postnatal body weights were similar to those of their wild-type
litter mates [12]. However, these mice had reduced spleen and
enlarged liver. A more recent study indicates that the IGFBP-2
knockout mice had reduced trabecular bone volume and
thickness in the adult male, but not female mice [13]. The
modest phenotypes may be due to the compensatory adjust-
ments in the expression of other IGFBPs and/or by maternal
factors delivered through the placenta [12].
The use of the zebrafish has provided new insights into our
understanding of the physiological functions of IGFBP-2 in
vertebrate development [14,15]. Targeted knockdown of zebrafish
IGFBP-2a by antisense morpholino (MO) resulted in delayed
development, reduced body growth, and disruptions to cardiovas-
cular development [14].
Many teleost fish, including zebrafish, experienced an additional
genome wide duplication event [16,17]. Since then, while many of
the duplicated genes have been lost, a substantial percentage of the
duplicates have been retained. As a result, fish often have two co-
orthologs in contrast to a single copy gene in humans and other
mammals. One such co-orthologous pair is the zebrafish igf-1r
genes [18,19]. The retention of a particular pair of genes provided
the unique opportunity to gain insights into the impact of
evolution in reshaping genes and their roles in physiology. In this
study, we have identified two IGFBP-2 genes in the zebrafish,
medaka, fugu, tetraodon, and the stickleback genomes using a
comparative genomics approach. Our molecular and functional
analysis on the two zebrafish IGFBP-2 genes suggests that they
have undergone subfunctionalization partitioning by evolving
distinct gene expression patterns, while their protein functionality
remains largely unchanged. Furthermore, taking advantage of the
amenability of the zebrafish model, we investigated the relative
contributions of the IGF binding domain, RGD, and HBD in
IGFBP-2 actions in vivo.
Results
Zebrafish and other teleost fish have two IGFBP-2 genes
In addition to the previously reported IGFBP-2 gene [20], we
identified another IGFBP-2 like gene (ENSDARP00000019643)
by searching the zebrafish genome. Using 59- and 39-RACE, its
full-length cDNA was determined (EF507265). The encoded
protein has a putative signal peptide of 17 amino acids (aa) and a
mature protein of 248 aa with a predicted molecular mass of
29.7 kDa. Structural analysis suggests that there are 12 cysteine
residues in its N-terminal domain (residues 1–79) and 6 cysteine
residues in its C-terminal domain (residues 152–231) (Fig. 1A). A
typical IGFBP motif is present in the N-domain and there is a
thyroglobulin-1 motif in the C-domain. Among various members
of the IGFBP family, the new IGFBP shares higher identities with
IGFBP-2 than with other known IGFBPs. The overall sequence
identities of this protein with the six human IGFBPs are 33%
(IGFBP-1), 44% (IGFBP-2), 32% (IGFBP-3), 37% (IGFBP-4),
33% (IGFBP-5), and 30% (IGFBP-6). Its identities with the known
zebrafish IGFBPs are 33% (IGFBP-1), 62% (IGFBP-2), 29%
(IGFBP-3), and 31% (IGFBP-5), respectively. Human and other
vertebrate IGFBP-2s contain an Arg-Gly-Asp (RGD) sequence in
the C-terminal domain [1,2]. An RGD motif is also present in the
zebrafish IGFBP at a.a.position 226 to 228. The putative heparin
binding motif (PKKXRP) located in the central domain in all the
known mammalian IGFBP-2 is absent in the zebrafish protein.
Phylogenetic analysis using full-length amino acid sequences of
known vertebrate IGFBPs grouped the newly identified IGFBP
into the IGFBP-2 clade (Fig. 1B), indicating that it is a co-ortholog
of human IGFBP-2. We therefore named the previously reported
zebrafish IGFBP-2 gene [20] as igfbp-2a, and this new gene as igfbp-
2b.
The genomic structure of igfbp-2a and igfbp-2b was determined
by searching the zebrafish genome database. igfbp-2a is 30,665 bp
long and contains 4 exons and 3 introns (Fig. 1C). The size and
overall structure of igfbp-2b are similar (Fig. 1C). The chromosomal
loci of igfbp-2a and igfbp-2b were also mapped. While igfbp-2a is
located on linkage group LG 6, igfbp-2b is mapped to LG 9
(Fig. 2A). The human IGFBP-2 gene resides on chromosome 2
adjacent to the IGFBP-5 gene in a tail-to-tail fashion [21]. In the
zebrafish genome, we found that zebrafish igfbp-2a and igfbp-5a are
located on LG 6, next to each other in a tail-to-tail fashion.
Likewise, zebrafish igfbp-2b and igfbp-5b are next to each other in a
tail-to-tail fashion. In the proximate regions, there are several
other zebrafish genes (tns1, tmem169) whose orthologs are located
on human chromosome 2 (Fig. 2A). This conserved synteny
strongly suggests that igfbp-2a and igfbp-2b are co-orthologs of the
human IGFBP-2 gene.
To determine whether the duplication of the IGFBP-2 gene is
unique to zebrafish or a more general phenomenon in teleost fish,
we searched the available genome databases for medaka (Oryzias
latipes), Fugu (Takifugu rubripes), Tetraodon (Takifugu nigroviridis), and
the three-spine stickleback (Gasterosteus aculeatus) and investigated
the evolutionary relationships within this subfamily. As in the case
of zebrafish, there are two igfbp-2 genes in all four teleoest species
and their primary structures are highly similar to that of IGFBP-2
(Fig. 1A). Phylogenetic analysis using mammalian IGFBP-2 as an
out-group indicated that the duplication of the igfbp-2a/b
subfamily expanded during the ray-fin fish genome duplication
(Fig. 2B).
Zebrafish igfbp-2b encodes a secreted protein that binds
IGFs
Previously, we have shown that zebrafish IGFBP-2a binds IGFs
with high affinity and specificity [20]. To determine whether igfbp-
2b also encodes a functional IGFBP, we constructed an expression
plasmid by subcloning the zebrafish IGFBP-2b ORF into the
pcDNA3.1/ Myc-His(-)A expression vector. As a positive control,
a pcDNA3.1/Myc-His(-)A-human IGFBP-2 plasmid was also
generated. After these plasmids were introduced into HEK293T
cells by transient transfection, conditioned media were prepared
and subjected to Western immunoblot and ligand blot analysis.
Both human and zebrafish IGFBP-2b had apparent sizes between
36 and 50 kDa on SDS-PAGE, likely due to the Myc tagging and
posttranslational modifications. Zebrafish IGFBP-2b had a slightly
smaller apparent size than human IGFBP-2 (Fig. 3A). Ligand
blotting showed that both zebrafish IGFBP-2b and human
IGFBP-2 proteins bind human IGF-1 (Fig. 3B). These results
suggest that zebrafish igfbp-2b also encodes a secreted protein that
binds to IGFs.
Evolution of IGFBP-2
PLoS ONE | www.plosone.org 2 December 2008 | Volume 3 | Issue 12 | e3926Zebrafish igfbp-2a and -2b exhibit distinct spatiotemporal
expression patterns
The spatial and temporal expression patterns of igfbp-2a and -2b
were determined by semi-quantitative RT-PCR and in situ
hybridization. As shown in Fig. 4A, IGFBP-2a mRNA was not
detectable until 10 hpf. The IGFBP-2a mRNA levels gradually
increased from 10 to 36 hpf and was maintained at high levels
thereafter. Likewise, IGFBP-2a mRNA was undetectable by in situ
hybridization in early embryonic stages. At 24 hpf, IGFBP-2a
mRNA was detected in the lens and cranial region (Fig. 4B). At 48
and 72 hpf, IGFBP-2a mRNA was detected in the brain boundary
vasculature. Expression in these regions persisted throughout the
hatching period (Fig. 4B). By 96 hpf, IGFBP-2a mRNA expression
was most abundant in the liver. This dynamic spatiotemporal
pattern of igfbp-2a is in good agreement with a previous study
[14]. As shown in Fig. 4A, IGFBP-2b mRNA was easily detected
by RT-PCR throughout embryogenesis. In agreement with the
RT-PCR data, in situ hybridization analysis showed that IGFBP-
2b mRNA was detectable at all stages examined. In early embryos,
the IGFBP-2b signal was detected in most, if not all, tissues at low
levels. At 96 hpf, IGFBP-2b mRNA expression was mostly
detected in the liver (Fig. 4B).
In the adult stage, the highest levels of IGFBP-2a mRNA were
found in the liver in both the male and the female (Fig. 4C). In
addition, modest levels of IGFBP-2a mRNA were seen in the
brain. Low levels of IGFBP-2a mRNA were also detected in the
muscle and gonad in male, but not female adult fish. There
appeared to be sexual dimorphism in the expression pattern of
IGFBP-2b mRNA in the adult stage. In the male, it was
exclusively expressed in the liver. In the female fish, it was not
only detected in the liver, but also in a number of other tissues,
including the gut, kidney, ovary, and muscle. These results
Figure 1. Structure of zebrafish IGFBP-2a and -2b. A) Amino acid sequence alignment of human IGFBP-2, mouse IGFBP-2, zebrafish IGFBP-2a
and -2b, and tetradon IGFBP-2a and -2b. The IGFBP motif, thyroglobulin motif, and RGD motif are underlined. B) Phylogenetic analysis of the IGFBP
gene family. Full-length sequences of IGFBPs were analyzed by MEGA4 with JTT matrix in neighbor-joining method. The reliability of each tree node
was assessed by the bootstrap method with 1000 replications. Numbers on branches are percentage of times that the two clades branched as sisters.
The clade with .50% bootstrap support was shown on each node. Human and mouse MAC25 genes were used as outgroups. The results indicate
that the newly identified IGFBP is most closely related to members of the IGFBP-2 subgroup. Similar results were obtained using the Maximum
Likelihood method and Maximum parsimony method. C) A schematic diagram showing the structure of zebrafish igfbp-2a and igfbp-2b. Filled boxes
represent open reading frame, open boxes represent untranslated region (UTR), and lines represent introns.
doi:10.1371/journal.pone.0003926.g001
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To determine if the two zebrafish IGFBP-2 genes have
associated with divergent regulatory elements, we analyzed a
2 kb fragment upstream of the cap site in igfbp-2a and igfbp-2b.
Transcription factor binding sites within the regions were
predicted by the on-line program Match using a library of
mononucleotide weight matrices from TRANSFAC 6.0 (www.
gene-regulation.com) with both core similarity and matrix
similarity of the transcription factor binding sites set higher than
0.85. The results revealed that the two promoter regions have
different regulatory element sites (Fig 4D).
Ectopic expression of IGFBP-2a and IGFBP-2b causes a
similar degree of reduction in embryonic growth and
development but has no effect on cell fate and
patterning
To determine and compare the biological activities of zebrafish
IGFBP-2a and -2b, we performed in vivo functional studies. For
this, capped mRNAs encoding zebrafish IGFBP-2a and -2b were
generated and introduced into zebrafish embryos by microinjec-
tion. As shown in Fig. 5A, embryos injected with either zebrafish
IGFBP-2a or -2b were morphologically normal, but they were
smaller in size and developmentally delayed compared to GFP
mRNA injected or wild type control embryos. The body lengths of
IGFBP-2a and IGFBP-2b injected embryos were 1.9260.14 mm
and 1.9960.17 mm at 24hpf, which are significantly smaller than
the 2.3260.22 mm and 2.2660.15 mm of the WT and GFP-
injected embryos (p,0.05). At 24 hpf, wild type embryos and GFP
mRNA injected control embryos had 29.460.6 and 28.060.8
somites, respectively. In comparison, embryos injected with either
zebrafish IGFBP-2a or IGFBP-2b had only 23.461.9 and
23.261.5 somites (p,0.05) (Fig 5B). They were developmentally
equivalent to wild type or GFP-injected embryos at ,20–21 hpf.
We next performed in situ hybridization to determine any potential
defects in patterning. Overexpression of either IGFBP-2a or
IGFBP-2b did not alter the brain and somite patterning, as
indicated by mRNA expression patterns of emx1 (labeling
Figure 2. Synteny and phylogenetic analysis of zebrafish IGFBPs. A) Conserved synteny between human and zebrafish IGFBP-2 genes.
Zebrafish igfbp-2a and igfbp-2b are located on linkage group (LG) 6 and 9, and human IGFBP-2 is located on chromosome 2. The human IGFBP-2 and
IGFBP-5 are neighboring genes in a tail-to-tail orientation. Likewise, zebrafish igfbp-2a/igfbp-5a and igfbp-2b/igfbp5-b are also neighboring genes in a
tail-to-tail orientation. B) Phylogenetic tree of IGFBP-2. Amino acid sequences of full-length IGFBP-2s were analyzed. Values on branches are
percentages that the two clades branched as sisters (1000 run). The results indicate that teleost igfbp-2a and igfbp-2b are likely a result of a fish-
specific genome duplication event.
doi:10.1371/journal.pone.0003926.g002
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hindbrain), egr2b (third and fifth rhombomeres), and myoD
(somite) (Fig 5C). These data suggest that the two IGFBP-2
isoforms have comparable biological activities. When expressed,
they both inhibited embryonic growth and developmental rates
without notable effects on cell fate determination or patterning.
The conserved growth inhibitory action of IGFBP-2 is
dependent on IGF binding but not its interaction with
heparin or integrin in vivo
To determine whether the biological action of IGFBP-2 is
conserved between teleost and humans, capped mRNAs encoding
human IGFBP-2 were generated and introduced into zebrafish
embryos. Embryos injected with human IGFBP-2 mRNA
phenocopied those of zebrafish IGFBP-2a and -2b mRNA injected
embryos, i.e., they were smaller, developmentally delayed, but
morphologically normal. Further quantitative analysis showed that
ectopic expression of human IGFBP-2 caused a comparable
decrease in growth and developmental rates (Fig. 6B).
In addition to its ability to bind IGFs, human IGFBP-2 was
reported to also act independently of IGF via its RGD and/or
heparin binding motifs in cultured mammalian cells [22,23]. The
in vivo significance of these in vitro findings, however, has not been
well studied. Because the biological action of IGFBP-2 is
conserved, we tested the functional importance of these motifs in
vivo by taking advantage of the zebrafish model. For this, human
IGFBP-2 mutants with altered ligand binding site (LBDm), RGD
(RGDm), and heparin-binding site (HBDm) were engineered
(Fig. 6A). The effects of these mutations on IGF binding and cell
surface association have been characterized in vitro by others
[6,22,23]. The corresponding capped mRNA was synthesized and
introduced into zebrafish embryos. While the RGDm and HBDm
had similar effects in slowing down growth and developmental
rates (Fig. 6B), embryos injected with LBDm mRNA were
indistinguishable from those of GFP mRNA injected controls in
morphology, body size, and somite number (Fig. 6B), suggesting
that altering the IGF binding site abolishes its biological activity.
These results suggest that IGFBP-2 is a conserved regulatory
protein and it acts by binding to IGF and inhibiting its actions in
vivo.
Discussion
In this study, we have demonstrated that the ortholog of
tetrapod IGFBP-2 has duplicated in the zebrafish and other teleost
fish. The conclusion that there are two IGFBP-2 genes in these
teleost genomes is supported by phylogenetic and detailed
structural data. Fish IGFBP-2a and -2b share much higher
identities with human IGFBP-2 than with other human IGFBPs.
All known vertebrate IGFBP-2s contain an RGD sequence in the
C-terminal domain[2]. An RGD motif is also present in the
zebrafish IGFBP-2a and -2b. Phylogenetic analyses grouped the
newly identified genes into the IGFBP-2 clade. The strongest
evidence came from the conserved synteny analysis. In humans,
IGFBP-2 and -5 genes are located next to each other on the same
chromosome in a tail-to-tail orientation [1]. In this study, we
found that igfbp-2a and igfbp-5a are neighboring genes located on
LG6 in a tail-to-tail orientation, resembling the situation of human
IGFBP-2 and -5 genes localized on chromosome 2. If igfbp-2a and
igfbp-5a arose by a chromosomal duplication event, one would
expect that igfbp-2b should also be located next to another igfbp-5b
gene. Indeed, our analysis shows that igfbp-2b and igfbp-5b genes
are neighboring genes on LG9. In addition to these IGFBP genes,
we were able to identify other orthologous genes between zebrafish
LG9 and human Chr.2. This conserved synteny strongly argues
that zebrafish igfbp-2a and igfbp-2b are co-orthologs of the human
IGFBP-2 gene.
The fact that there are also two IGFBP-2 genes in the medaka,
fugu, tetraodon, and the stickleback implies that the origin of this
gene duplication is ancient, likely before the divergence of ray-fin
fish and tetrapods. This notion is also supported by the
phylogenetic analysis data and is in good agreement with the
notion that a genome duplication event occurred in the teleost
lineage ,350 million years ago, prior to the beginning of the
teleost radiation [16,17,24]. While the majority of duplicated
genes have been lost since the genome duplication event in the
teleost lineage, a substantial percentage of the duplicates have
been retained. When the putative zebrafish orthologs of 74 human
genes on chromosome 17 were examined, Postlethwait et al. found
that 15 (20%) are present as duplicate genes [25]. Like the
mammals, the IGF signaling systems in teleosts are composed of
IGF ligands, receptors, and IGFBPs [8,15]. It has been shown
previously that zebrafish contain two igf-1r genes and two insulin
receptor genes [18]. Recent studies suggest that there are two igf-1
genes and two igf-2 genes in zebrafish (our unpublished data).
Additionally, there is also evidence indicating that zebrafish have
two igfbp-1 genes [26]. In this study, we have shown that there are
two igfbp-2 and two igfbp-5 genes in zebrafish. Therefore, it appears
that all major components in the fish IGF signaling pathway are
retained as duplicates. This high rate of gene retention in genes
belonging to the IGF signaling pathway in the ray-fin fish is
interesting. Unlike mammals, most teleosts do not reach a static
adult size but continue to grow indeterminantly well beyond
puberty. Given its central importance in growth regulation, it is
possible that the retention of many duplicates of major players in
the IGF signaling system may play an important role in the
continuous growth pattern of the teleost.
The retention of two functional igfbp-2 genes in zebrafish also
provided a unique opportunity to gain insights into how the
IGFBP genes may have evolved through partitioning of ancestral
functions. Subfunction partitioning can involve protein structural
Figure 3. Zebrafish igfbp-2b encodes a secreted protein that
binds IGFs. Conditioned media was prepared from HEK293T cells
transfected with pCMV-human IGFBP-2-Myc (hIGFBP-2) or pCMV-
zebrafish IGFBP-2b-Myc plasmids. The conditioned media were
analyzed by Western immunoblotting (WB) using c-Myc antibody (left
panel) and ligand blotting using DIG-labeled human IGF-1 (right panel).
doi:10.1371/journal.pone.0003926.g003
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PLoS ONE | www.plosone.org 5 December 2008 | Volume 3 | Issue 12 | e3926Figure 4. Temporal and spatial expression patterns of igfbp-2a and igfbp-2b. A) RT-PCR analysis result. The developmental stages are shown
at the top, hpf, hour post fertilization. N.C., negative control. odc, (ornithine decarboxylase). B) In situ hybridization analysis of whole mounted
embryos. Embryos of indicated stages were analyzed. Scale bar=100 mm. C) Tissue distribution of igfbp-2a and igfbp-2b mRNA in male and female
adult fish. D) Schematic diagram comparing the 59-flanking region of igfbp-2a and igfbp-2b 2,000 bp before the cap site are shown. Close symbols
indicate DNA binding elements in forward orientation and open symbols indicate those in reverse orientation.
doi:10.1371/journal.pone.0003926.g004
Evolution of IGFBP-2
PLoS ONE | www.plosone.org 6 December 2008 | Volume 3 | Issue 12 | e3926Evolution of IGFBP-2
PLoS ONE | www.plosone.org 7 December 2008 | Volume 3 | Issue 12 | e3926changes and has important functional and evolutionary conse-
quences [17]. Taking advantage of the zebrafish model, we
examined the spatial and temporal expression patterns and
biological activities of the duplicated igfbp-2 genes. Analysis of
expression patterns for zebrafish igfbp-2a and igfbp-2b clearly reveal
spatial and temporal subfunction partitioning. While zebrafish
igfbp-2b is expressed throughout the entire early developmental
stages in a ubiquitous fashion, igfbp-2a mRNA is not detected until
10 hpf in a highly tissue specific and dynamic manner. In the adult
stage, these two duplicates are expressed in overlapping yet distinct
tissues. While both igfbp-2a and -2b are highly expressed in the liver
in both the adult male and female fish, only IGFBP-2a mRNA was
detected in the brain. There appears to be a sexual dimorphism in
their expression patterns. IGFBP-2a mRNA was also detected in
the muscle and gonad in the male at low levels but not the female
adult fish. In contrast, IGFBP-2b mRNA was detected in the gut,
kidney, ovary, and muscle in adult female fish only. These gender
specific expression patterns are interesting in light of the recent
findings that male mice had 66% higher circulating IGFBP-2
levels compared with females [13]. While the duplicated zebrafish
IGFBP-2 genes exhibit clear temporal and spatial partitioning in
their expression, our previous and current biochemical analysis
suggest that the duplicated igfbp-2 genes have similar biological
properties. Both zebrafish IGFBP-2a and -b are secreted proteins
that are capable of IGF binding. Furthermore, overexpression of
zebrafish IGFBP-2a and -2b in zebrafish embryos had nearly
identical phenotypes, i.e., they caused a similar decrease in the
growth and developmental rates. These data suggest that the
duplicated igfbp-2 genes encode two functionally equivalent
proteins but have evolved distinct spatial and temporal expression
patterns.
A number of in vivo studies using transgenic mice have shown
that IGFBP-2 has a predominantly inhibitory effect on IGF actions
[4]. Our functional analysis using transgenic zebrafish suggests
that the inhibitory action of IGFBP-2 is conserved across species.
When overexpressed in developing zebrafish embryos, human
IGFBP-2 had a growth inhibitory effect similar to that of zebrafish
IGFBP-2. While the inhibitory effect of IGFBP-2 can be explained
by its competition for IGF binding with the IGF-1R based on
biochemical and cell culture studies [2,4,5], in vivo evidence
supporting this theory is still scarce. In this study, we have tested
this model using transgenic zebrafish embryos. Our data shows
that mutation of the major IGF binding site of human IGFBP-2
completely abolished its biological activity in this in vivo animal
Figure 6. The growth inhibitory effect of IGFBP-2 is evolutionarily conserved and is dependent on its IGF binding but not its
interaction with heparin or integrin. A) A schematic diagram showing the native and mutant IGFBP-2 structure. The ligand binding mutant
(LBDm) was engineered following Forbes et al. [6], heparin binding domain mutant (HBDm) following Russo et al. [22], and RGD mutant (RGDm)
following Wang et al. [23]. B) Effects of expression of proteins shown in A) on embryo growth and developmental rate in vivo. Capped mRNA
(800 pg/embryo) was injected into 1–2 cell stage embryos. The embryos were raised to 24 hpf and body length and somite number were
determined. Results are from three independent microinjection experiments. The total embryo number for each group is 91(gfp), 94 (higfbp2), 131
(LBDm), 79 (HBDm), and 81(RGDm). Values are represented as Means6S.E. (n=3). Groups with common letters are not significantly different from
each other (p,0.05).
doi:10.1371/journal.pone.0003926.g006
Figure 5. Ectopic expression of IGFBP-2a and IGFBP-2b causes a similar degree of reduction in embryonic growth and development
but has no effect on cell fate and patterning. A) Representative images of wild-type, GFP mRNA (800 pg/embryo), IGFBP-2a mRNA (800 pg/
embryo), or IGFBP-2b mRNA 800 pg/embryo) injected embryos at 24 hpf. B) Body length and somite number of the groups indicated. Results are
from three independent microinjection experiments. The total embryo number for each group is 79 (wt), 95(gfp), 79(igfbp-2a), and 100 (igfbp-2b).
Values are represented as means6S.E. (n=3). Groups with common letters are not significantly different from each other (p,0.05). C) Whole mount
in situ hybridization analysis of various marker genes in gfp mRNA-injected control (left column), igfbp-2a mRNA-injected (central column), and igfbp-
2b mRNA-injected (right column) embryos at 24 hpf: emx1 expression in the forebrain; pax2a expression in the optic stalk, mid-hindbrain boundary,
and hindbrain; egr2b expression in the third and fifth rhombomeres of the hindbrain; rx1 expression in the retina; myoD expression in the somatic
myotome. Scale bar=100 mm. Similar patterns were observed in all embryos examined in each group (n=8–14).
doi:10.1371/journal.pone.0003926.g005
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is a conserved regulatory protein and it acts primarily by binding
to and inhibiting IGF actions during early development in vivo.
IGF-independent actions of IGFBP-2 have been documented in
cultured mammalian cells [2,4]. It has been suggested that an
RGD motif in human IGFBP-2 may be partially responsible for its
cell surface association. The RGD motif in human IGFBP-2 has
been reported to be involved in binding to integrin and this
interaction is important for IGFBP-2-induced SNB19 glioma cell
migration [23]. Since all known vertebrate IGFBP-2s, including
the zebrafish IGFBP-2b reported in this study, have an RGD motif
in their C-domains, we tested the possible role of RGD in
mediating any biological actions of IGFBP-2 in transgenic
zebrafish in vivo. We discovered that mutation of the RGD motif
in human IGFBP-2 did not cause any notable changes in the
growth inhibitory effects of IGFBP-2 in this animal model. This is
consistent with the report by [11], which showed that overexpres-
sion of an RGE IGFBP-2 mutant did not affect IGFBP-2 cell
surface association in transgenic mice.
In addition to the RGD motif, human IGFBP-2 possesses a
putative heparin-binding motif (HBD). Recent studies have
suggested that the association of IGFBP-2 with the cell surface
or the extracellular matrix is due to its ability to bind to
proteoglycans [22], but the relative contributions of the HBD in
vivo is unknown. Taking advantage of the zebrafish model and the
fact that the biological action of human IGFBP-2 is conserved, we
investigated the role of the HBD in vivo. Our results have shown
that transgenic zebrafish overexpressing the HBDm were
essentially indistinguishable from those overexpressing native
human IGFBP-2, indicating that the mutation of the HBD does
not alter the growth inhibitory action of IGFBP-2. This conclusion
is further supported by the fact that the two zebrafish IGFBP-2s
had similar biological effects even though the HBD motif is not
present in these proteins [27].
In conclusion, we have shown that there are two functional
IGFBP-2 genes in zebrafish and other teleosts, which likely
resulted from a genome wide duplication event before the
beginning of the teleost radiation. Both zebrafish igfbp-2a and -
2b encode secreted proteins that bind IGFs. Gene expression and
functional analysis suggest that the two fish IGFBP-2 genes have
undergone subfunctionalization partitioning by evolving distinct
gene expression patterns, while their protein functionality remains
largely unchanged. We further show that IGFBP-2 is a conserved
regulatory protein and it inhibits embryo growth and development
primarily by binding to IGF and inhibiting its actions in vivo. This
study has not only provided novel insights into the functional
evolution of IGFBPs but also demonstrated the utility of the
zebrafish model system in the study of IGFBP physiology.
Materials and Methods
Chemicals
Reagents and chemicals were purchased from Fischer Scientific
(Pittsburgh, PA) unless noted otherwise. RNase-free DNase and
restriction enzymes were obtained from Promega (Madison, WI)
and New England Biolabs (Beverly, MA). Pfu Turbo DNA
polymerase was from Stratagene (La Jolla, CA). Superscript II
reverse transcriptase (RT) and oligonucleotide primers were
obtained from Invitrogen Life Technologies, Inc. (Carlsbad, CA).
Experimental animals
Zebrafish (Danio rerio) were maintained on a 14 h light/10 h
dark cycle. Fertilized eggs, obtained by natural cross, were raised
in embryo medium at 28.5uC and staged according to Kimmel et
al. [28]. For in situ hybridization analysis, embryo medium was
supplemented with 0.003% (w/v) 2-phenylthiourea to inhibit
embryo pigment formation. All experiments were conducted in
accordance with the guidelines approved by the University
Committee on the Use and Care of Animals at the University of
Michigan.
Molecular cloning and physical mapping
Using the human IGFBP-2 and zebrafish IGFBP-2 amino acid
sequence as queries, we searched the zebrafish genome database
(http://www.ensembl.org/Danio_rerio/blastview), the medaka
genome database (http://www.ensembl.org/Oryzias_latipes/
blastview), the stickleback genome database (http://www.ensembl.
org/Gasterosteus_aculeatus/blastview), the tetraodon genome
database (http://www.ensembl.org/Tetraodon_nigroviridis/
blastview), and the Fugu genome database (http://www.
ensembl.org/Takifugu_rubripes/blastview). We found an addi-
tional zebrafish IGFBP-2 gene (ENSDARP00000019643), two
medaka IGFBP-2 genes (ENSORLG00000014695 and EN-
SORLG00000002232), two stickleback IGFBP-2 (EN-
SGACG00000014280 and ENSGACG00000002506), two tetra-
odon IGFBP-2 genes (GSTENG00016851001 and
GSTENG00015886001) and two fugu IGFBP-2 genes (EN-
STRUG00000013702 And ENSTRUG00000003825). The full-
length sequence of the new zebrafish IGFBP-2 was determined by
59- and 39- rapid amplification of cDNA ends (RACE) using the
SMART RACE kit (Clontech, Mountain View, CA). Amino acid
sequences of IGFBP-2s were aligned by CLUSTAL X. Phyloge-
netic analysis was done using full-length amino acid sequences by
Neighbor-joining method in the MEGA4 program with protein
Poisson distances. Gap sites in the alignment were not used in the
phylogenetic reconstruction. The reliability of the estimated tree
was evaluated by the bootstrap method with 1000 pseudo-
replications. Synteny analysis was carried out based on Danio
rerio Zv6 and Homo sapiens Build 36.3 (http://www.ensembl.
org/Homo_sapiens/index.html)and data from zebrafish and
human synteny map. Genomic structure was determined by
searching the zebrafish genome (http://www.ensembl.org/Danio_
rerio/index.html).
Reverse transcription (RT)-PCR and whole mount in situ
hybridization
Total RNA was isolated from adult zebrafish tissues and whole
embryos using TRIzol reagent (Invitrogen Life Technologies, Inc.,
Carlsbad, CA) following the manufacturer’s instruction. One mgo f
RNA was reverse-transcribed to single strand cDNA using
SuperScript II reverse transcriptase according to the manufactur-
er’s instructions. RT-PCR was performed with two sets of primers
(IGFBP-2a: 59- CGATGTTGTCCTATGTGAGT -39 and 59-
GATCACCTCTTATCAGTGGA-39 IGFBP-2b: 59- GCATGT-
CTCTTGCATTGCTC -39 and 59- CGGACGAGGGTATC-
TGGACA-39) using Taq-DNA polymerase with ornithine decar-
boxylase (odc) mRNA as internal control as reported previously
(21).
For whole mount in situ hybridization analysis, plasmids
encoding zebrafish IGFBP-2a 39 UTR and IGFBP-2b partial
ORF with 39UTR cDNAs or other genes were linearized by
restriction enzyme digestion, followed by in vitro transcription
reactions with either T7 or SP6 RNA polymerase, and then
generated as digoxigenin (DIG)-labeled RNA probes. The
specificity of each of the IGFBP-2 riboprobe was verified by dot-
blot analysis and shown not to cross-react with each other’s target.
Hybridization was carried out as described previously [18]. Images
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Nikon Eclipse E600 microscope (Melville, NY).
Construction of expression plasmids
To produce recombinant IGFBP-2 proteins for biochemical
analysis, cDNAs encoding ORFs for zebrafish IGFBP-2b and
human IGFBP-2 were amplified by PCR with restriction enzyme
sites and Kozak sequence containing primers (zebrafish IGFBP-
2b: forward 59-TCCTCTCGAGCCACCATGTCTCTTG-
CATTGCTCTGCAGTTTG-39; reverse 59-TGTGAAGC-
TTTTTCTGCTGGGCGGTGGGTGGTTCCAGT-39; human
IGFBP-2: forward 59-TCCTCTCGAGCCACCATGCTGCC-
GAGAGTGGGCTG-39, and reverse 59-TGTGAAGCTTCTG-
CATCCGCTGGGTGTGCA-39). The amplified cDNA was
subcloned into the pcDNA3.1/ Myc-His(-)A expression vector
(Invitrogen).
For in vivo functional studies, zebrafish IGFBP-2a expression
constructs were engineered. First, DNA fragments containing the
entire ORF of zebrafish IGFBP-2a in which the stop codon was
mutated were generated by PCR (forward 59-TCCTCTCGA
GCCACCATGTTGTCCTATGTGAGTTGCGGCT-39; and
reverse 59-TGTGAAGCTT GTTTGGAGGGTCGACAGATG-
GATC-39) and subcloned into the pcDNA3.1/ Myc-His(-)A
construct using the XhoI and Hind III sites. To determine the
importance of the ligand binding domain (LBD), heparin binding
domain (HBD), and the RGD motif of IGFBP-2, three mutants
(LBDm forward 59-TCCTCTCGAGCCACCATGCTGCCGA-
GAGTGGGCTG-39and reverse 59-TGTGAAGCTTCTTGT-
CACAGTTGGGGATGTGC-39, HBDm forward 59- CCTGG-
AGGAGCCCAACAACCTGGCACCACCCCCTGCC-39 and
reverse 59-GGCAGGGGGTGGTGCCAGGTTGTTGGGCT-
CCTCCAGG-39, and RGDm forward 59-CCACCATCC-
GGGGGGAACCCGAGTG-39and reverse59- CACTCGGGTT-
CCCCCCGGATGGTGG-39) were generated by PCR using Pfu
Turbo DNA Polymerase (Stratagene, La Jolla, CA) according to
published sequences [6,22,23]. For this pcDNA3.1-hIGFBP-2 was
used as template. The LBDm (truncated IGFBP2) was generated
by the PCR method. For HBDm and RGDm, 0.25 mM of each
PCR primer, 2 mM of dNTP, 1.25 units of Pfu Turbo DNA
Polymerase, and 16Cloned Pfu DNA Polymerase Reaction Buffer
with 5% DMSO were used to mutagenize the template DNA by
PCR (95uC1 9;9 5 uC5 0 0,5 5 uC5 0 0,6 8 uC7 9, for 18 cycles; 68uC
79) in a total volume of 50 ml. Each reaction was incubated with 10
units of Dpn I at 37uC for one hour. The sequences were
confirmed by T7 sequencing primer and a reverse primer at
downstream of multiple cloning sites of pcDNA3.1/ Myc-His (-) A.
All plasmids were sequenced at the University of Michigan DNA
Sequencing Core Facility.
Expression of recombinant IGFBP-2 proteins
Recombinant c-Myc- and 6xHistidine-tagged human and
zebrafish IGFBP-2b were produced by transfecting the expression
plasmids into human embryonic kidney (HEK) 293T cells. Cells
were cultured in high glucose Dulbecco’s modified Eagle’s
medium with 10% fetal bovine serum. The transfected cells were
maintained with culture medium containing 10% FBS and
antibiotics (100 units/ml Penicillin and 100 mg/mL streptomycin
sulfate, Gibco BRL). After the cells reached confluence, they were
incubated with serum free media (SFM) for another 48 h. The
SFM containing recombinant proteins was harvested, and the
protein expression was confirmed by Western immunoblotting and
ligand blotting as described below.
Western immunoblotting and ligand blotting analysis
The SFM containing recombinant proteins was separated by
SDS-PAGE and transferred to Immobilon P membranes (Milli-
pore Corp., Bedford, MA) and subjected to Western blot using
monoclonal anti-c-myc (clone 9E10/SC40; Santa Cruz, CA) as
reported previously. Ligand blot analysis was performed using
digoxigenin-labeled human IGF-I following published procedure
[29].
Microinjection experiment
Capped mRNA synthesis was carried out using a commercial kit
and linearized plasmid DNA as template (mMESSAGE mMA-
CHINE kit; Ambion, Inc.). mRNA (800 pg per embryo) was
microinjected into zebrafish embryos at the 1–2 cell stage as
reported previously (14). GFP mRNA injected and wild type
embryos were used as controls. After injection, embryos were
placed in embryo rearing medium [30] and kept at 28.5uC. Body
length and somite number were measured at 24 hpf as described
previously [31].
Statistics- Values are means6S.E.M. Differences among groups
were analyzed by one way ANOVA followed by Tukey’s Multiple
Comparison Test using GraphPad Prism version 5.00 (San Diego,
CA). Significance was accepted at p,0.05.
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